To the Editor: We read the article “Can mean platelet volume and mean platelet volume/platelet count ratio be used as a diagnostic marker for sepsis and systemic inflammatory response syndrome?” by Ates et al.1 In that very well-designed and well-presented study, Ates and coworkers tried to determine whether the mean platelet volume (MPV) and MPV/platelet count ratio can be used in the study of sepsis and systemic inflammatory response syndrome (SIRS). They concluded that although no significant reduction was observed in the platelet values between patients with sepsis and SIRS, the MPV and MPV/platelet ratio values were found to have significant differences. The ready availability of MPV measurements at no additional cost may encourage its wider use in clinical practice.
A complete blood count is a comparatively routine, cheap, practical, and easy examination method that gives important information about inflammation.2 MPV, as a part of platelet function, is a widely used laboratory marker associated with coronary artery disease based on inflammatory conditions.3 At present, increased MPV levels were also demonstrated in atrial fibrillation,4 cerebrovascular disease, peripheral artery disease, stroke, malignancy, ulcerative colitis and celiac disease, and Behcet disease.5,6 All these conditions are related to endothelial dysfunction on the basis of inflammation. 7 Also, medications such as aspirin that may affect the MPV values should also be reported with other medications of the patients.8
Moreover, the authors did not mention about the type of the tube (ethylenediaminetetraacetic acid [EDTA] or citrate) that contained the sample blood collected. It is well known that MPV increases over time in EDTA-anticoagulated samples. The MPV increases up to 30% within 5 min of exposure to EDTA and increases further by 10%–15% over the next 2 h with impedance technology. So, the optimum time of MPV measurement is about 2 h after blood sample collection in the EDTA tube.8 Another limitation of the EDTA tube is that EDTA-dependent pseudothrombocytopenia is seen between 0.1% and 0.5% of the general population.9 This phenomenon is also related to substantial and time-dependent changes in MPV, and must hence be recognized to prevent inappropriate interpretation of spurious platelet size variations. Importantly, EDTA also generates a small shape change and swelling in platelets, so that the MPV measured in citrated blood can differ from that assessed in the EDTA blood of the same donor.
In conclusion, it is believed that the findings of the current study will lead to further studies examining the relationship between MPV and inflammation. However, MPV alone without other inflammatory indicators may not provide enough information about the inflammatory status.10 It is strongly recommended that MPV should be assessed together with other serum inflammatory markers.
REFERENCES
- 1.Ates S, Oksuz H, Dogu B, Bozkus F, Ucmak H, Yanıt F. Can mean platelet volume and mean platelet volume/platelet count ratio be used as a diagnostic marker for sepsis and systemic inflammatory response syndrome? Saudi Med J. 2015 Oct;36(10):1186–90. doi: 10.15537/smj.2015.10.10718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Demirkol S, Balta Ş, Arslan Z, Küçük U, Ünlü M. Klinik pratiğimizin kolay, ucuz ve invaziv olmayanenflamasyon belirteci olarak ortalama trombosit hacmi. Turk Kardiyol Dern Ars. 2013 Sep;41(6):575. [PubMed] [Google Scholar]
- 3.Celik T, Balta S, Ozturk C, Kaya MG, Aparci M, Yildirim OA, et al. Predictors of No-Reflow Phenomenon in Young Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Angiology. 2015 Sep 13; doi: 10.1177/0003319715605977. [DOI] [PubMed] [Google Scholar]
- 4.Balta S, Demirkol S, Kucuk U, Unlu M. Hemostatic markers can be pivotal roles of risk factors for new-onset atrial fibrillation. Platelets. 2013 Apr 3; doi: 10.3109/09537104.2013.778398. [DOI] [PubMed] [Google Scholar]
- 5.Balta I, Balta S, Koryurek OM, Demirkol S, Celik T, Akbay G, et al. Mean platelet volume is associated with aortic arterial stiffness in patients with Behçet’s disease without significant cardiovascular involvement. J Eur Acad Dermatol Venereol. 2014 Oct 25;28(10):1388–93. doi: 10.1111/jdv.12297. [DOI] [PubMed] [Google Scholar]
- 6.Ekiz O, Balta I, Sen BB, Rifaioglu EN, Ergin C, Balta S, et al. Mean platelet volume in recurrent aphthous stomatitis and Behçet disease. Angiology. 2014 Feb 13;65(2):161–5. doi: 10.1177/0003319713492375. [DOI] [PubMed] [Google Scholar]
- 7.Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M, et al. The Relation Between Atherosclerosis and the Neutrophil-Lymphocyte Ratio. Clin Appl Thromb Hemost. 2015 Feb 9; doi: 10.1177/1076029615569568. In press. [DOI] [PubMed] [Google Scholar]
- 8.Balta S, Mikhailidis DP, Kurtoglu E, Demirkol S. Mean platelet volume in patients undergoing percutaneous coronary intervention. Platelets. 2015 Jan 31;26(3):269–70. doi: 10.3109/09537104.2013.842207. [DOI] [PubMed] [Google Scholar]
- 9.Uslu AU, Inal S, Balta S. Assessment of Platelet-Lymphocyte Ratio Based on EDTA-Dependent Pseudothrombocytopenia. Angiology. 2015 Jun 29; doi: 10.1177/0003319715591331. [DOI] [PubMed] [Google Scholar]
- 10.Balta S, Demirkol S, Unlu M, Celik T. Other inflammatory markers should be kept in mind when assessing the mean platelet volume. Platelets. 2014 Jan 5;25(7):552–3. doi: 10.3109/09537104.2013.775643. [DOI] [PubMed] [Google Scholar]